Lexicon Pharmaceuticals (NASDAQ: LXRX) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $372 thousand versus the consensus estimate of $600 thousand.

For earnings history and earnings-related data on Lexicon Pharmaceuticals (LXRX) click here.

Earnings